Alnylam Pharmaceuticals | 10-Q: Quarterly report
Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
Alnylam Pharmaceuticals | ARS: Annual Report to Security Holders
Alnylam Pharmaceuticals | DEFA14A: Others
Alnylam Pharmaceuticals | DEF 14A: Definitive information statements
Alnylam Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Fitzgerald Kevin Joseph
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanguler Tolga
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenstreet Yvonne
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Jeffrey V.
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Garg Pushkal
Alnylam Pharmaceuticals | 8-K: Current report
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SHARP PHILLIP A
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenstreet Yvonne
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Poulton Jeffrey V.
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanguler Tolga
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Garg Pushkal
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Franchini Indrani Lall
Alnylam Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tanguler Tolga
Alnylam Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Greenstreet Yvonne
No Data